The table below shows BioXcel Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$206.00K
$98.00K
$120.00K
$168.00K
$214.00K
$1.10M
Cost of revenue
$283.00K
$11.00K
$107.00K
$14.00K
$1.17M
$62.00K
Gross profit
-
-
-
-
-
-
R&D
$2.96M
$8.74M
$10.26M
$4.55M
$5.10M
$8.03M
BTAI annual revenue (10-K history)
BioXcel Therapeutics, Inc. reported annual revenue of $642.00K for fiscal year 2025. That is down 71.7% from $2.27M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.